Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 38, Issue 4, 2009, Pages 362-370

  Zhang, Lei ^a   Yang, Xiao ^a   Zhong, Lai Ping ^a   Zhou, Xiao Jian ^a   Pan, Hong Ya ^a   Wei, Kui Jie ^a   Li, Jiang ^a   Chen, Wan Tao ^a   Zhang, Zhi Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Annexin A1; Immunohistochemistry; Oral squamous cell carcinoma; Real time PCR; Western blotting

Indexed keywords

LIPOCORTIN 1; MESSENGER RNA; MOLECULAR MARKER; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER TISSUE; CARCINOGENESIS; CELL LINE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; FEMALE; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TISSUE DIFFERENTIATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANNEXIN A1; CARCINOMA, SQUAMOUS CELL; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 62949192061     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00678.x     Document Type: Article

References (66)

1. Kademani D. Oral cancer. Mayo Clin Proc 2007 82 : 878 87.
2. Petersen PE. The World Oral Health Report 2003: continuous improvement of oral health in the 21st century-the approach of WHO Global Oral Programme. Community Dent Oral Epidemiol 2003 31 (Suppl 3 23.
3. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin 2002 52 : 195 215.
4. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005 55 : 74 108.
5. Sdek P, Zhang ZY, Cao J, Pan HY, Chen WT, Zheng JW. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7. Int J Oral Maxillofac Surg 2006 35 : 653 7.
6. Zhong LP, Pan HY, Zhou XJ, et al. Characteristics of a cancerous cell line, HIOEC-B(a)P-96, induced by benzo(a)pyrene from human immortalized oral epithelial cell line. Arch Oral Biol 2008 53 : 443 52.
7. Fontana S, Alessandro R, Barranca M, et al. Comparative proteome profiling and functional analysis of chronic myelogenous leukemia cell lines. J Proteome Res 2007 6 : 4330 42.
8. Ferrari G, Pastorelli R, Buchi F, et al. Comparative proteomic analysis of chronic myelogenous leukemia cells: inside the mechanism of imatinib resistance. J Proteome Res 2007 6 : 367 75.
9. Harris MN, Ozpolat B, Abdi F, et al. Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia. Blood 2004 104 : 1314 23.
10. Noble JL, Dua RS, Coulton GR, Isacke CM, Gui GP. A comparative proteinomic analysis of nipple aspiration fluid from healthy women and women with breast cancer. Eur J Cancer 2007 43 : 2315 20.
11. Li DQ, Wang L, Fei F, et al. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry. Proteomics 2006 6 : 3352 68.
12. Ying-Tao Z, Yi-Ping G, Lu-Sheng S, Yi-Li W. Proteomic analysis of differentially expressed proteins between metastatic and non-metastatic human colorectal carcinoma cell lines. Eur J Gastroenterol Hepatol 2005 17 : 725 32.
13. Alfonso P, Núñez A, Madoz-Gurpide J, Lombardia L, Sánchez L, Casal JI. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 2005 5 : 2602 11.
14. Pshezhetsky AV, Fedjaev M, Ashmarina L, et al. Subcellular proteomics of cell differentiation: quantitative analysis of the plasma membrane proteome of Caco-2 cells. Proteomics 2007 7 : 2201 15.
15. Tian T, Hao J, Xu A, et al. Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci 2007 98 : 1265 74.
16. Chen G, Gharib TG, Huang CC, et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res 2002 8 : 2298 305.
17. Ali IU, Xiao Z, Malone W, et al. Plasma proteomic profiling: search for lung cancer diagnostic and early detection markers. Oncol Rep 2006 15 : 1367 72.
18. Li C, Xiao Z, Chen Z, et al. Proteome analysis of human lung squamous carcinoma. Proteomics 2006 6 : 547 58.
19. Song HY, Liu YK, Feng JT, et al. Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. J Cancer Res Clin Oncol 2006 132 : 92 8.
20. He YF, Liu YK, Lu HJ, Chen J, Yang PY. Comparative proteomic analysis of primary mouse liver c-Kit-(CD45/TER119)-stem/progenitor cells. J Cell Biochem 2007 102 : 936 46.
21. Craven RA, Stanley AJ, Hanrahan S, et al. Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma. Proteomics 2006 6 : 2853 64.
22. Hwa JS, Park HJ, Jung JH, et al. Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis. J Korean Med Sci 2005 20 : 450 5.
23. Orenes-Piñero E, Cortón M, González-Peramato P, et al. Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach. J Proteome Res 2007 6 : 4440 8.
24. Sheng KH, Yao YC, Chuang SS, Wu H, Wu TF. Search for the tumor-related proteins of transition cell carcinoma in Taiwan by proteomic analysis. Proteomics 2006 6 : 1058 65.
25. Qi Y, Chiu JF, Wang L, Kwong DL, He QY. Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 2005 5 : 2960 71.
26. Nishimori T, Tomonaga T, Matsushita K, et al. Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin. Proteomics 2006 6 : 1011 8.
27. Chen CY, Jia JH, Zhang MX, Zhou YB, Zhang RM, Yu XP. Comparative proteomics of apoptosis initiation induced by 5-fluorouracil in human gastric cancer. Chin J Physiol 2006 49 : 31 8.
28. Lin YW, Lai HC, Lin CY, et al. Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervix. Int J Gynecol Cancer 2006 16 : 1216 24.
29. He QY, Chen J, Kung HF, Yuen AP, Chiu JF. Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 2004 4 : 271 8.
30. Chen J, He QY, Yuen AP, Chiu JF. Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 2004 4 : 2465 75.
31. Turhani D, Krapfenbauer K, Thurnher D, Langen H, Fountoulakis M. Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis 2006 27 : 1417 23.
32. Lo WY, Tsai MH, Tsai Y, et al. Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin Chim Acta 2007 376 : 101 7.
33. Koike H, Uzawa K, Nakashima D, et al. Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach. Int J Oncol 2005 27 : 59 67.
34. Mlynarek AM, Balys RL, Su J, Hier MP, Black MJ, Alaoui-Jamali MA. A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2007 133 : 910 8.
35. Staab CA, Ceder R, Jägerbrink T, et al. Bioinformatics processing of protein and transcript profiles of normal and transformed cell lines indicates functional impairment of transcriptional regulators in buccal carcinoma. J Proteome Res 2007 6 : 3705 17.
36. Coupade CD, Gillet R, Bennoun M, Briand P, Russo-Marie F, Solito E. Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology 2000 31 : 371 80.
37. Croxtall J, Flower R, Perretti M. The role of lipocortin 1 in the regulation of A549 cell proliferation and leukocyte migration. J Lipid Mediat 1993 6 : 295 302.
38. Hsiang CH, Tunoda T, Whang YE, Tyson DR, Ornstein DK. The impact of altered Annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells. Prostate 2006 66 : 1413 24.
39. McKanna JA. Lipocortin 1 in apoptosis: mammary regression. Anat Rec 1995 242 : 1 10.
40. Sakamoto T, Repasky WT, Uchida K, Hirata A, Hirata F. Modulation of cell death pathways to apoptosis and necrosis of H2O2-treated rat thymocytes by lipocortin I. Biochem Biophys Res Commun 1996 220 : 643 7.
41. Shen D, Nooraie F, Elshimali Y, et al. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol 2006 37 : 1583 91.
42. Shen D, Chang HR, Chen Z, et al. Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. Biochem Biophys Res Commun 2005 326 : 218 27.
43. Kang JS, Calvo BF, Maygarden SJ, Caskey LS, Mohler JL, Ornstein DK. Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res 2002 8 : 117 23.
44. Patton KT, Chen HM, Joseph L, Yang XJ. Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia. Histopathology 2005 47 : 597 601.
45. Paweletz CP, Ornstein DK, Roth MJ, et al. Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res 2000 60 : 6293 7.
46. Silistino-Souza R, Rodrigues-Lisoni FC, Cury PM, et al. Annexin 1: differential expression in tumor and mast cells in human larynx cancer. Int J Cancer 2007 120 : 2582 9.
47. Hu N, Flaig MJ, Su H, et al. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Clin Cancer Res 2004 10 : 6013 22.
48. Liu Y, Wang HX, Lu N, et al. Translocation of annexin I from cellular membrane to the nuclear membrane in human esophageal squamous cell carcinoma. World J Gastroenterol 2003 9 : 645 9.
49. Xia SH, Hu LP, Hu H, et al. Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas. Oncogene 2002 21 : 6641 8.
50. Vishwanatha JK, Salazar E, Gopalakrishnan VK. Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer 2004 4 : 8.
51. Bai XF, Ni XG, Zhao P, et al. Overexpression of Annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol 2004 10 : 1466 70.
52. Guzmán-Aránguez A, Olmo N, Turnay J, et al. Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. J Cell Biochem 2005 94 : 178 93.
53. Dai Z, Liu YK, Cui JF, et al. Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis. Proteomics 2006 6 : 5857 67.
54. Masaki T, Tokuda M, Ohnishi M, et al. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma. Hepatology 1996 24 : 72 81.
55. Ahn SH, Sawada H, Ro JY, Nicolson GL. Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin Exp Metastasis 1997 15 : 151 6.
56. Mulla A, Christian HC, Solito E, Mendoza N, Morris JF, Buckingham JC. Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clin Endocrinol 2004 60 : 107 19.
57. Falini B, Tiacci E, Liso A, et al. Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet 2004 363 : 1869 70.
58. Zhong LP, Chen WT, Zhang CP, Zhang ZY. Increased CK19 expression correlated with pathologic differentiation grade and prognosis in oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 104 : 377 84.
59. Zhong LP, Zhang CP, Li J, Chen WT, Zhang ZY. Increase of Cyfra 21-1 concentration in saliva from oral squamous cell carcinoma patients. Arch Oral Biol 2007 52 : 1079 87.
60. Sobin LH, Wittekind CH, eds. International Union Against Cancer (UICC). TNM classification of malignant tumours, 6th edn. New York : Wiley-Liss, 2002.
61. Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization classification of tumours. pathology and genetics of head and neck tumours. Lyon : IARC Press, 2005.
62. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976 72 : 248 54.
63. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods 2001 25 : 402 8.
64. Zhong LP, Li J, Zhang CP, Zhu HG, Sun J, Zhang ZY. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients. Arch Oral Biol 2007 52 : 740 7.
65. Califano J, van P, Westra W, Nawroz H, Clayman G, Piantadosi S. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996 56 : 2488 92.
66. Lim LH, Pervaiz S. Annexin 1: the new face of an old molecule. FASEB J 2007 21 : 968 75.